HUP9901244A3 - 3-pyrazolecarboxamide derivatives having cannabinoid receptor affinity, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds - Google Patents
3-pyrazolecarboxamide derivatives having cannabinoid receptor affinity, intermediates, preparation and use thereof, pharmaceutical compositions containing these compoundsInfo
- Publication number
- HUP9901244A3 HUP9901244A3 HU9901244A HUP9901244A HUP9901244A3 HU P9901244 A3 HUP9901244 A3 HU P9901244A3 HU 9901244 A HU9901244 A HU 9901244A HU P9901244 A HUP9901244 A HU P9901244A HU P9901244 A3 HUP9901244 A3 HU P9901244A3
- Authority
- HU
- Hungary
- Prior art keywords
- intermediates
- compounds
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- BNYCHCAYYYRJSH-UHFFFAOYSA-N 1h-pyrazole-5-carboxamide Chemical class NC(=O)C1=CC=NN1 BNYCHCAYYYRJSH-UHFFFAOYSA-N 0.000 title 1
- 102000018208 Cannabinoid Receptor Human genes 0.000 title 1
- 108050007331 Cannabinoid receptor Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000543 intermediate Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9514547A FR2742148B1 (fr) | 1995-12-08 | 1995-12-08 | Nouveaux derives du pyrazole-3-carboxamide, procede pour leur preparation et compositions pharmaceutiques les contenant |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9901244A2 HUP9901244A2 (hu) | 1999-08-30 |
HUP9901244A3 true HUP9901244A3 (en) | 2000-12-28 |
Family
ID=9485291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9901244A HUP9901244A3 (en) | 1995-12-08 | 1996-12-06 | 3-pyrazolecarboxamide derivatives having cannabinoid receptor affinity, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds |
Country Status (34)
Country | Link |
---|---|
US (1) | US5925768A (hu) |
EP (2) | EP0868420B1 (hu) |
JP (1) | JP3510270B2 (hu) |
KR (1) | KR100488610B1 (hu) |
CN (1) | CN1101813C (hu) |
AR (1) | AR004364A1 (hu) |
AT (1) | ATE191211T1 (hu) |
AU (1) | AU718763B2 (hu) |
BR (1) | BR9611986A (hu) |
CA (1) | CA2239489C (hu) |
CZ (1) | CZ294307B6 (hu) |
DE (1) | DE69607484T2 (hu) |
DK (1) | DK0868420T3 (hu) |
EE (1) | EE04674B1 (hu) |
ES (1) | ES2148820T3 (hu) |
FR (1) | FR2742148B1 (hu) |
GR (1) | GR3033626T3 (hu) |
HU (1) | HUP9901244A3 (hu) |
IL (1) | IL124801A (hu) |
IS (1) | IS4765A (hu) |
MX (1) | MX9804565A (hu) |
MY (1) | MY115228A (hu) |
NO (1) | NO310683B1 (hu) |
NZ (1) | NZ323962A (hu) |
PL (1) | PL186466B1 (hu) |
PT (1) | PT868420E (hu) |
RU (1) | RU2170230C2 (hu) |
SI (1) | SI0868420T1 (hu) |
SK (1) | SK283706B6 (hu) |
TR (1) | TR199801041T2 (hu) |
TW (1) | TW402594B (hu) |
UA (1) | UA44913C2 (hu) |
WO (1) | WO1997021682A1 (hu) |
ZA (1) | ZA9610299B (hu) |
Families Citing this family (96)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0979228A4 (en) * | 1997-03-18 | 2000-05-03 | Smithkline Beecham Corp | CANNABINOID RECEPTOR AGONISTS |
DE69910373T2 (de) * | 1998-05-04 | 2004-04-01 | The University Of Connecticut, Farmington | Analgetische und immunomodulierende cannabinoiden |
US7589220B2 (en) * | 1998-06-09 | 2009-09-15 | University Of Connecticut | Inhibitors of the anandamide transporter |
US7897598B2 (en) | 1998-06-09 | 2011-03-01 | Alexandros Makriyannis | Inhibitors of the anandamide transporter |
US7276613B1 (en) | 1998-11-24 | 2007-10-02 | University Of Connecticut | Retro-anandamides, high affinity and stability cannabinoid receptor ligands |
US7161016B1 (en) | 1998-11-24 | 2007-01-09 | University Of Connecticut | Cannabimimetic lipid amides as useful medications |
US6566560B2 (en) | 1999-03-22 | 2003-05-20 | Immugen Pharmaceuticals, Inc. | Resorcinolic compounds |
CN1377261A (zh) | 1999-03-22 | 2002-10-30 | 免疫力药品有限公司 | 治疗免疫疾病 |
US7741365B2 (en) * | 1999-10-18 | 2010-06-22 | University Of Connecticut | Peripheral cannabinoid receptor (CB2) selective ligands |
US7119108B1 (en) * | 1999-10-18 | 2006-10-10 | University Of Connecticut | Pyrazole derivatives as cannabinoid receptor antagonists |
MXPA02005100A (es) * | 1999-10-18 | 2003-09-25 | Alexipharma Inc | Derivados de pirazol antagonistas de receptor de canabinoide. |
US6900236B1 (en) * | 1999-10-18 | 2005-05-31 | University Of Connecticut | Cannabimimetic indole derivatives |
MXPA02005103A (es) | 1999-10-18 | 2003-09-25 | Alexipharma Inc | Ligandos selectivos del receptor de canabinoide (cb2) perifericos. |
US8084467B2 (en) * | 1999-10-18 | 2011-12-27 | University Of Connecticut | Pyrazole derivatives as cannabinoid receptor antagonists |
US6943266B1 (en) * | 1999-10-18 | 2005-09-13 | University Of Connecticut | Bicyclic cannabinoid agonists for the cannabinoid receptor |
US7393842B2 (en) * | 2001-08-31 | 2008-07-01 | University Of Connecticut | Pyrazole analogs acting on cannabinoid receptors |
FR2800372B1 (fr) | 1999-11-03 | 2001-12-07 | Sanofi Synthelabo | Derives tricycliques d'acide 1-benzylpyrazole-3- carboxylique, leur preparation, les medicaments en contenant |
WO2002026728A2 (en) * | 2000-09-28 | 2002-04-04 | Immugen Pharmaceuticals, Inc. | Antiviral methods and compounds |
WO2002026224A2 (en) * | 2000-09-28 | 2002-04-04 | Immugen Pharmaceuticals, Inc. | Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation |
US8449908B2 (en) | 2000-12-22 | 2013-05-28 | Alltranz, Llc | Transdermal delivery of cannabidiol |
EP1361876A4 (en) * | 2001-01-26 | 2004-03-31 | Univ Connecticut | NEW CANNABIMIMETIC LIGANDS |
ATE478670T1 (de) | 2001-01-29 | 2010-09-15 | Univ Connecticut | Rezeptor-selektive cannabimimetische aminoalkylindole |
US7507767B2 (en) * | 2001-02-08 | 2009-03-24 | Schering Corporation | Cannabinoid receptor ligands |
US7067539B2 (en) * | 2001-02-08 | 2006-06-27 | Schering Corporation | Cannabinoid receptor ligands |
US7057076B2 (en) * | 2001-07-13 | 2006-06-06 | University Of Connecticut | Bicyclic and tricyclic cannabinoids |
WO2003007887A2 (en) * | 2001-07-20 | 2003-01-30 | Merck & Co., Inc. | Substituted imidazoles as cannabinoid receptor modulators |
JP2005507875A (ja) * | 2001-08-31 | 2005-03-24 | ユニバーシティ オブ コネチカット | カンナビノイド受容体に作用する新規なピラゾール類似体 |
US7666867B2 (en) * | 2001-10-26 | 2010-02-23 | University Of Connecticut | Heteroindanes: a new class of potent cannabimimetic ligands |
PL369952A1 (en) | 2001-11-14 | 2005-05-02 | Schering Corporation | Cannabinoid receptor ligands |
WO2003061699A1 (fr) * | 2001-12-27 | 2003-07-31 | Japan Tobacco, Inc. | Remedes pour affections allergiques |
US20040171613A1 (en) * | 2001-12-27 | 2004-09-02 | Japan Tobacco Inc. | Therapeutic agent for non-immediate type allergic diseases |
NZ535349A (en) | 2002-03-08 | 2007-01-26 | Signal Pharm Inc | JNK inhibitors with chemotherapeutic agents in a combination therapy for treating or preventing cancer and other proliferative disorders in refractory patients in particular |
CN1652766A (zh) * | 2002-03-18 | 2005-08-10 | 免疫力药品有限公司 | 间苯二酚和大麻素的局部制剂及其施用方法 |
US6825209B2 (en) | 2002-04-15 | 2004-11-30 | Research Triangle Institute | Compounds having unique CB1 receptor binding selectivity and methods for their production and use |
JP2005533809A (ja) | 2002-06-19 | 2005-11-10 | シェーリング コーポレイション | カンナビノイドレセプタアゴニスト |
US6972291B2 (en) * | 2002-07-02 | 2005-12-06 | Bernstein Richard K | Method for reducing food intake |
DE60308699T2 (de) * | 2002-08-21 | 2007-08-23 | Glaxo Group Ltd., Greenford | 2-phenylamino-4-trifluoromethyl-5-(benzyl- oder pyridin-4-ylmethyl)carbamoylpyrimidin-derivate als selektive cb2 cannabinoid-rezeptor modulatoren |
UY27939A1 (es) * | 2002-08-21 | 2004-03-31 | Glaxo Group Ltd | Compuestos |
CA2496097A1 (en) | 2002-08-23 | 2004-03-04 | University Of Connecticut | Keto cannabinoids with therapeutic indications |
GB0222493D0 (en) * | 2002-09-27 | 2002-11-06 | Glaxo Group Ltd | Compounds |
GB0222495D0 (en) * | 2002-09-27 | 2002-11-06 | Glaxo Group Ltd | Compounds |
US7765162B2 (en) * | 2002-10-07 | 2010-07-27 | Mastercard International Incorporated | Method and system for conducting off-line and on-line pre-authorized payment transactions |
MXPA05004115A (es) * | 2002-10-18 | 2005-06-22 | Pfizer Prod Inc | Ligandos del receptor cannabionoide y usos de los mismos. |
US7129239B2 (en) * | 2002-10-28 | 2006-10-31 | Pfizer Inc. | Purine compounds and uses thereof |
CA2506895A1 (en) | 2002-11-25 | 2004-06-10 | Schering Corporation | Cannabinoid receptor ligands |
US7247628B2 (en) * | 2002-12-12 | 2007-07-24 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
US7329658B2 (en) * | 2003-02-06 | 2008-02-12 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
US7176210B2 (en) * | 2003-02-10 | 2007-02-13 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
WO2004078261A1 (en) * | 2003-03-07 | 2004-09-16 | The University Court Of The University Of Aberdeen | Cannabinoid receptor inverse agonists and neutral antagonists as therapeutic agents for the treatment of bone disorders |
AR043633A1 (es) | 2003-03-20 | 2005-08-03 | Schering Corp | Ligandos de receptores de canabinoides |
US7145012B2 (en) | 2003-04-23 | 2006-12-05 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
US7141669B2 (en) * | 2003-04-23 | 2006-11-28 | Pfizer Inc. | Cannabiniod receptor ligands and uses thereof |
US20040214856A1 (en) * | 2003-04-23 | 2004-10-28 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
US7268133B2 (en) * | 2003-04-23 | 2007-09-11 | Pfizer, Inc. Patent Department | Cannabinoid receptor ligands and uses thereof |
EP1622876A1 (en) * | 2003-05-07 | 2006-02-08 | Pfizer Products Inc. | Cannabinoid receptor ligands and uses thereof |
US7232823B2 (en) | 2003-06-09 | 2007-06-19 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
US20040259887A1 (en) * | 2003-06-18 | 2004-12-23 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
FR2856683A1 (fr) * | 2003-06-25 | 2004-12-31 | Sanofi Synthelabo | Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application en therapeutique |
GB0402357D0 (en) * | 2004-02-03 | 2004-03-10 | Glaxo Group Ltd | Novel compounds |
GB0402356D0 (en) * | 2004-02-03 | 2004-03-10 | Glaxo Group Ltd | Novel compounds |
GB0402355D0 (en) * | 2004-02-03 | 2004-03-10 | Glaxo Group Ltd | Novel compounds |
EP1718620A1 (en) * | 2004-02-23 | 2006-11-08 | Glaxo Group Limited | Pyrimidine derivatives as cannabinoid receptor modulators |
US20080280868A1 (en) * | 2004-02-24 | 2008-11-13 | Andrew John Eatherton | Pyridine Derivatives and Their Use as Cb2 Receptor Modulators |
ITMI20041032A1 (it) * | 2004-05-24 | 2004-08-24 | Neuroscienze S C A R L | Compositi farmaceutici |
CA2571058A1 (en) * | 2004-06-22 | 2006-01-05 | Schering Corporation | Cannabinoid receptor ligands |
KR20070041717A (ko) | 2004-07-12 | 2007-04-19 | 카딜라 핼쓰캐어 리미티드 | 카나비노이드 수용체 조절자인 트리시클릭 피라졸 유도체들 |
US20060025448A1 (en) | 2004-07-22 | 2006-02-02 | Cadila Healthcare Limited | Hair growth stimulators |
FR2875230A1 (fr) * | 2004-09-13 | 2006-03-17 | Sanofi Aventis Sa | Derives de pyrazole condense, leur preparation et leur application en therapeutique |
WO2006056873A2 (en) * | 2004-11-29 | 2006-06-01 | Warner-Lambert Company Llc | Therapeutic pyrazolo[3,4-b] pyridines and indazoles |
AU2006203845A1 (en) * | 2005-01-10 | 2006-07-13 | Alexandros Makriyannis | Novel heteropyrrole analogs acting on cannabiniod receptors |
US8853205B2 (en) | 2005-01-10 | 2014-10-07 | University Of Connecticut | Heteropyrrole analogs acting on cannabinoid receptors |
FR2887550A1 (fr) * | 2005-06-24 | 2006-12-29 | Sanofi Aventis Sa | Derives de 1-benzylpyrazole-3-acetamide, leur preparation et leur application en therapeutique |
ATE538650T1 (de) * | 2006-03-10 | 2012-01-15 | Jenrin Discovery | Cannabinoid-rezeptor-antagonisten / inverse agonisten zur behandlung von übergewicht |
WO2007121687A1 (fr) * | 2006-04-26 | 2007-11-01 | Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China | Dérivés du 4-méthyl-1h-diaryl pyrazole et leur utilisation comme médicaments |
US7763607B2 (en) * | 2006-04-27 | 2010-07-27 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators |
JP2009534439A (ja) * | 2006-04-27 | 2009-09-24 | ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cbxカンナビノイド受容体モジュレータ及びカリウムチャンネルモジュレータを含む医薬組成物 |
US20070254863A1 (en) * | 2006-04-27 | 2007-11-01 | Jochen Antel | Use of CBx cannabinoid receptor modulators as potassium channel modulators |
US7875647B2 (en) * | 2006-09-29 | 2011-01-25 | Green Cross Corporation | Heteroaryl-pyrazole derivatives as cannabinoid CB1 receptor antagonists |
JP5437812B2 (ja) | 2006-12-18 | 2014-03-12 | 7ティーエム ファーマ エイ/エス | Cb1受容体モジュレーター |
GB0702862D0 (en) * | 2007-02-14 | 2007-03-28 | Univ Aberdeen | Therapeutic compounds |
EP1985295A1 (en) | 2007-04-04 | 2008-10-29 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Selective inhibitors of CB2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders |
CN101314591B (zh) * | 2007-05-30 | 2010-09-29 | 上海阳帆医药科技有限公司 | 吡唑类高选择性大麻受体-1拮抗剂和/或反向激动剂 |
FR2916758B1 (fr) * | 2007-06-04 | 2009-10-09 | Sanofi Aventis Sa | Derives de 1-benzylpyrazole, leur preparation et leur application en therapeutique |
US8293786B2 (en) * | 2007-07-30 | 2012-10-23 | Alltranz Inc. | Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same |
WO2009029727A1 (en) * | 2007-08-28 | 2009-03-05 | Vanderbilt University | Cannabinoid receptor targeted agent |
US8133904B2 (en) * | 2007-09-07 | 2012-03-13 | Jenrin Discovery, Inc. | Cannabinoid receptor antagonists/inverse agonists useful for treating obesity |
CA2698527A1 (en) | 2007-09-20 | 2009-03-26 | Solvay Pharmaceuticals B.V. | 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists |
US20090247619A1 (en) * | 2008-03-06 | 2009-10-01 | University Of Kentucky | Cannabinoid-Containing Compositions and Methods for Their Use |
US10053444B2 (en) | 2009-02-19 | 2018-08-21 | University Of Connecticut | Cannabinergic nitrate esters and related analogs |
EP2311443A1 (en) | 2009-10-15 | 2011-04-20 | Rheinische Friedrich-Wilhelms-Universität | Pharmaceutical composition containing cannabinoid-receptor 2 antagonists |
CN102329192A (zh) * | 2011-09-30 | 2012-01-25 | 山东天一化学股份有限公司 | 溴化苄的合成方法 |
WO2015188073A1 (en) * | 2014-06-06 | 2015-12-10 | Research Triangle Institute | Apelin receptor (apj) agonists and uses thereof |
ES2894919T3 (es) | 2015-06-12 | 2022-02-16 | Vettore Llc | Inhibidores de MCT4 para el tratamiento de enfermedades |
CA3046212A1 (en) | 2016-12-12 | 2018-06-21 | Vettore, LLC | Heterocyclic inhibitors of mct4 |
US10420089B2 (en) | 2017-08-10 | 2019-09-17 | At&T Intellectual Property I, L.P. | Adaptive two-stage downlink control channel structure for code block group based fifth generation (5G) or other next generation systems |
CA3125847A1 (en) | 2020-07-27 | 2022-01-27 | Makscientific, Llc | Process for making biologically active compounds and intermediates thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5015651A (en) * | 1988-01-07 | 1991-05-14 | E. I. Du Pont De Nemours And Company | Treatment of hypertension with 1,2,4-angiotensin II antagonists |
FR2665898B1 (fr) * | 1990-08-20 | 1994-03-11 | Sanofi | Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
FR2692575B1 (fr) * | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
FR2713225B1 (fr) * | 1993-12-02 | 1996-03-01 | Sanofi Sa | N-pipéridino-3-pyrazolecarboxamide substitué. |
FR2714057B1 (fr) * | 1993-12-17 | 1996-03-08 | Sanofi Elf | Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant. |
-
1995
- 1995-12-08 FR FR9514547A patent/FR2742148B1/fr not_active Expired - Fee Related
-
1996
- 1996-12-06 EP EP96941716A patent/EP0868420B1/fr not_active Expired - Lifetime
- 1996-12-06 CN CN96199643A patent/CN1101813C/zh not_active Expired - Fee Related
- 1996-12-06 UA UA98062944A patent/UA44913C2/uk unknown
- 1996-12-06 AR ARP960105525A patent/AR004364A1/es active IP Right Grant
- 1996-12-06 SK SK758-98A patent/SK283706B6/sk not_active IP Right Cessation
- 1996-12-06 HU HU9901244A patent/HUP9901244A3/hu unknown
- 1996-12-06 TR TR1998/01041T patent/TR199801041T2/xx unknown
- 1996-12-06 BR BR9611986A patent/BR9611986A/pt not_active IP Right Cessation
- 1996-12-06 EP EP98401565A patent/EP0885889A3/fr not_active Withdrawn
- 1996-12-06 CA CA002239489A patent/CA2239489C/en not_active Expired - Fee Related
- 1996-12-06 AT AT96941716T patent/ATE191211T1/de not_active IP Right Cessation
- 1996-12-06 PT PT96941716T patent/PT868420E/pt unknown
- 1996-12-06 WO PCT/FR1996/001953 patent/WO1997021682A1/fr active IP Right Grant
- 1996-12-06 ES ES96941716T patent/ES2148820T3/es not_active Expired - Lifetime
- 1996-12-06 CZ CZ19981775A patent/CZ294307B6/cs not_active IP Right Cessation
- 1996-12-06 NZ NZ323962A patent/NZ323962A/xx not_active IP Right Cessation
- 1996-12-06 RU RU98112606/04A patent/RU2170230C2/ru not_active IP Right Cessation
- 1996-12-06 SI SI9630209T patent/SI0868420T1/xx unknown
- 1996-12-06 JP JP52178697A patent/JP3510270B2/ja not_active Expired - Fee Related
- 1996-12-06 DK DK96941716T patent/DK0868420T3/da active
- 1996-12-06 ZA ZA9610299A patent/ZA9610299B/xx unknown
- 1996-12-06 PL PL96327177A patent/PL186466B1/pl not_active IP Right Cessation
- 1996-12-06 IL IL12480196A patent/IL124801A/en not_active IP Right Cessation
- 1996-12-06 KR KR10-1998-0704296A patent/KR100488610B1/ko not_active IP Right Cessation
- 1996-12-06 AU AU11010/97A patent/AU718763B2/en not_active Ceased
- 1996-12-06 DE DE69607484T patent/DE69607484T2/de not_active Expired - Lifetime
- 1996-12-06 US US09/077,767 patent/US5925768A/en not_active Expired - Lifetime
- 1996-12-06 EE EE9800171A patent/EE04674B1/xx not_active IP Right Cessation
- 1996-12-07 TW TW085115150A patent/TW402594B/zh active
- 1996-12-07 MY MYPI96005160A patent/MY115228A/en unknown
-
1998
- 1998-06-05 NO NO19982589A patent/NO310683B1/no not_active IP Right Cessation
- 1998-06-08 IS IS4765A patent/IS4765A/is unknown
- 1998-06-08 MX MX9804565A patent/MX9804565A/es not_active IP Right Cessation
-
2000
- 2000-06-07 GR GR20000401312T patent/GR3033626T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9901244A3 (en) | 3-pyrazolecarboxamide derivatives having cannabinoid receptor affinity, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds | |
HUP9701169A3 (en) | Cycloalkano-pyridine derivatives, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds | |
HUP9901159A3 (en) | Substituted benzylaminopiperidine derivatives and use thereof, pharmaceutical compositions containing these compounds | |
HUP9702409A3 (en) | 1,4,5-trisubstituted imidazole derivatives useful as cytokine, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds | |
HUP9901243A3 (en) | Quinazoline derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds | |
HUP9801556A3 (en) | Phenylpyridazinone -derivatives, intermediates, preparation and use thereof and herbicide compositions containing these compounds | |
HUP9700709A3 (en) | 1,2-diphenylpyrrole derivatives, use thereof and pharmaceutical compositions containing these compounds | |
NZ304901A (en) | Taxoid derivatives, preparation thereof and pharmaceutical compositions containing same | |
HUP0002869A3 (en) | Benzothiophenecarboxamide derivatives, pharmaceutical compositions thereof and intermediates | |
HUP9901037A3 (en) | Piperazine derivatives,preparation and use thereof, pharmaceutical compositions containing these compounds | |
HUP9700328A3 (en) | Heteroaryl-oxazolidinones, process for their preparation, pharmaceutical compositions containing the same, their use and intermediates | |
HUP0102307A3 (en) | Bispidine derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates | |
HUP9900617A3 (en) | Novel indole-, indoline- or tetrahydrokinoline derivatives as acat and lipid peroxidation inhibitors, use thereof, pharmaceutical compositions containing these compounds | |
HUP9900975A3 (en) | Quinoxalinedione derivatives, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds | |
HUP9901184A3 (en) | Antibacterial benzoxazine and pyrido-oxazine derivatives, intermediates, pharmaceutical compositions containing these compounds, preparation and use thereof | |
HUP9901096A3 (en) | Indole derivatives, preparation and use thereof, pharmaceutical composition containing these compounds | |
SI0918059T1 (en) | Substituted imidazoline derivatives, their preparation, their use, and pharmaceutical compositions containing them | |
HUP9701194A3 (en) | 4-hydroxy-piperidine derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds | |
HUP9902454A3 (en) | Substituted 1,2,3,4-tetrahydronaphthalene derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds | |
IL118426A0 (en) | Pharmaceutical composition containing 1,3-bis-triazolyl-2- propanol derivative | |
HUP0002272A3 (en) | Aroyl-piperazine derivatives, their preparation pharmaceutical compositions containing them and their use | |
IL116746A0 (en) | Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions | |
IL112589A (en) | Polysubstituted-3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives process and novel intermediates for their preparation and pharmaceutical compositions containing them | |
HUP9801386A3 (en) | Indazolecarboxamide derivatives, preparation thereof and pharmaceutical compositions containing them | |
HUP9900865A3 (en) | Anti-viral benzimidazole derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |